Prognosis of sentinel node staged patients with primary cutaneous melanoma

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Elsaeßer, Otmar ^a   Leiter, Ulrike ^a   Buettner, Petra G ^b   Eigentler, Thomas K ^a   Meier, Friedegund ^a   Weide, Benjamin ^a   Metzler, Gisela ^a   Breuninger, Helmut ^a   Garbe, Claus ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CUTANEOUS MELANOMA; FEMALE; FOLLOW UP; GERMANY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MELANOMA; MICROMETASTASIS; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PRIMARY TUMOR; PROBABILITY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RISK ASSESSMENT; SENTINEL LYMPH NODE BIOPSY; SKIN ULCER; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

EID: 84855995606     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029791     Document Type: Article

References (22)

1. Balch CM, Morton DL, Gershenwald JE, McMasters KM, Nieweg OE, et al. (2009) Sentinel node biopsy and standard of care for melanoma. J Am Acad Dermatol 60: 872-5.
2. Phan GQ, Messina JL, Sondak VK, Zager JS, (2009) Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control 16: 234-9.
3. Yee VS, Thompson JF, McKinnon JG, Scolyer RA, Li LX, et al. (2005) Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol 12: 429-39.
4. Essner R, Conforti A, Kelley MC, Wanek L, Stern S, et al. (1999) Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma. Ann Surg Oncol JID- 9420840 6: 442-9.
5. Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, et al. (2006) Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355: 1307-17.
6. Morton DL, Cochran AJ, Thompson JF, (2008) The rationale for sentinel-node biopsy in primary melanoma. Nat Clin Pract Oncol 5: 510-1.
7. McMasters KM, Wong SL, Edwards MJ, Ross MI, Chao C, et al. (2001) Factors that predict the presence of sentinel lymph node metastasis in patients with melanoma. Surgery 130: 151-6.
8. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, et al. (2005) Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg 242: 302-11.
9. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, et al. (2000) Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Ann Surg Oncol 7: 469-74.
10. Chao C, Wong SL, Ross MI, Reintgen DS, Noyes RD, et al. (2002) Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg 184: 520-4.
11. Gadd MA, Cosimi AB, Yu J, Duncan LM, Yu L, et al. (1999) Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134: 381-7.
12. Gershenwald JE, Colome MI, Lee JE, Mansfield PF, Tseng C, et al. (1998) Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol JID- 8309333 16: 2253-60.
13. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, Ruka W, (2003) Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes-one institution's experience. Melanoma Res 13: 35-43.
14. Wagner JD, Gordon MS, Chuang TY, Coleman JJ, III, (2000) Current therapy of cutaneous melanoma. Plast Reconstr Surg 105: 1774-99.
15. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Ding S, et al. (2010) Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol 28: 2452-9.
16. Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, et al. (2001) Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol JID- 8309333 19: 3622-34.
17. Garbe C, (2003) A rational approach to the follow-up of melanoma patients. Recent Results Cancer Res JID- 0044671 160: 205-15.
18. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, et al. (2009) Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 27: 6199-206.
19. Zogakis TG, Essner R, Wang HJ, Turner RR, Takasumi YT, et al. (2005) Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg 140: 865-71.
20. van der Ploeg AP, van Akkooi AC, Rutkowski P, Nowecki ZI, Michej W, et al. (2011) Prognosis in patients with sentinel node-positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria. J Clin Oncol 29: 2206-14.
21. Kunte C, Geimer T, Baumert J, Konz B, Volkenandt M, et al. (2010) Prognostic factors associated with sentinel lymph node positivity and effect of sentinel status on survival: an analysis of 1049 patients with cutaneous melanoma. Melanoma Res 20: 330-7.
22. Mandala M, Imberti GL, Piazzalunga D, Belfiglio M, Labianca R, et al. (2009) Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Eur J Cancer 45: 2537-45.